Clinical trials referenced in this document:
Documents that mention this clinical trial
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
https://doi.org/10.1007/s41030-023-00222-2
Funding for this research was provided by:
Mallinckrodt Pharmaceuticals
Article History
Received: 30 December 2022
Accepted: 20 March 2023
First Online: 19 April 2023